The table below shows BIOGEN INC.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
$2.48B
$2.53B
$2.65B
$2.43B
$2.47B
$2.46B
Cost of revenue
$661.00M
$674.40M
$605.00M
$629.30M
$638.70M
$546.00M
Gross profit
-
-
-
-
-
-
R&D
-
-
-
-
-
-
SG&A
BIIB annual revenue (10-K history)
BIOGEN INC. reported annual revenue of $9.89B for fiscal year 2025. That is up 2.2% from $9.68B in fiscal 2024. Over the 10 fiscal years shown, annual revenue declined from $11.45B (FY 2016) to $9.89B. Figures come from the company's audited annual reports as filed with the SEC.
